A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...

How DERM works. For lesions identified as pre-cancerous or cancerous, an NHS dermatologist reviews the case virtually and determines the appropriate management plan. For patients with black or brown ...

What happens on the skin often begins much deeper. In women living with chronic inflammation, pain, and recurrent skin ...

DERM (Deep Ensemble for Recognition of Malignancy), which was approved in the UK as a Class IIA medical device in 2022, analyses images to assess and triage skin lesions, and may be able to refer ...

3 Committee discussion. The diagnostics advisory committee considered evidence on Deep Ensemble for Recognition of Malignancy (DERM) to assess and triage skin lesions referred to the urgent suspected ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in ...

DERM provides a suspected diagnosis and triages the case. Patients with benign lesions may be redirected to non-urgent pathways and receive written safety-netting advice. Suspicious lesions are ...